Literature DB >> 8293190

The immunopathology of Alzheimer's disease and some related disorders.

R N Kalaria1.   

Abstract

Current evidence clearly indicates that elements of the immune system are involved in the pathogenesis of the principal lesions characterizing Alzheimer's disease (AD). Findings are in accord with features associated with both the innate and adaptive immune mechanisms involved in a predominantly local inflammatory response within the parenchyma. Many of the features are unique to AD, presumably related to the unusual properties of beta amyloid protein. Remarkably, the brain holds the capacity to produce almost all the immune system mediators which largely seem to be generated by glia comprising both astrocytes and microglia. While a variety of humoral mediators including classical acute phase proteins (and serpins) are increased and released, the complement seems most intrinsically involved. The cellular response is elaborated by microglia which seem the main immunocompetent cells partaking in the response. These appear to function as pluripotent macrophages expressing both classes of MHC antigens. Further characterization of this interesting response to cerebral amyloidosis will be challenging.

Entities:  

Mesh:

Year:  1993        PMID: 8293190     DOI: 10.1111/j.1750-3639.1993.tb00761.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.

Authors:  C J Heyser; E Masliah; A Samimi; I L Campbell; L H Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 3.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

Review 4.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  A neuronal C5a receptor and an associated apoptotic signal transduction pathway.

Authors:  I Farkas; L Baranyi; M Takahashi; A Fukuda; Z Liposits; T Yamamoto; H Okada
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

Review 6.  The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation.

Authors:  William E Klunk; Chester A Mathis
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

7.  Increase of acidic fibroblast growth factor in the brains of hamsters infected with either 263K or 139H strains of scrapie.

Authors:  Xuemin Ye; Richard I Carp
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

8.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells.

Authors:  A V Albright; J Martín; M O'Connor; F González-Scarano
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 3.739

Review 10.  [Premature immunosenescence: a pathogenetic factor in Alzheimer's disease?].

Authors:  E Richartz-Salzburger; E Stransky; C Laske; N Köhler
Journal:  Nervenarzt       Date:  2010-07       Impact factor: 1.297

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.